Stocksigma LogoStocksigma Logo

Venmax Drugs Convenes NCLT-Directed Shareholder Meeting for Hatri Pharma Amalgamation

Venmax Drugs and Pharmaceuticals convened an NCLT-directed equity shareholders meeting on 24th Oct'26 to approve the Scheme of Amalgamation with Hatri

Venmax Drugs Convenes NCLT-Directed Shareholder Meeting for Hatri Pharma Amalgamation

Venmax Drugs and Pharmaceuticals Ltd · Court Convened Meeting · 24 Oct 2026, 9:11 pm

Venmax Drugs Convenes NCLT-Directed Shareholder Meeting for Hatri Pharma Amalgamation Venmax Drugs and Pharmaceuticals convened an NCLT-directed equity shareholders meeting on 24th Oct'26 to approve the Scheme of Amalgamation with Hatri Pharma Private Limited under Sections 230–232 of the Companies Act, 2013. The meeting followed an order dated 7th Sep'26 from the NCLT Hyderabad Bench-II. Shareholders were briefed on the scheme's rationale, valuation, and exchange ratios. Remote e-voting was conducted between 21st Oct'26 and 23rd Oct'26 alongside e-voting during the meeting; final voting results will be disclosed upon receipt of the Scrutinizer's Report.

Original exchange filing (PDF)

More announcements from Venmax Drugs and Pharmaceuticals Ltd

All Venmax Drugs and Pharmaceuticals Ltd announcements